MVF Price sensitive 20 Nov 2026, 9:23 AM

FY27 Trading Update

Monash Ivf Group Ltd

Monash IVF Group Provides FY27 Trading Update

Key points

  • Australian stimulated-cycle market contracted by 3.2% in Q1 FY27
  • MVF's market share remained stable compared to June 2026
  • MVF expects underlying FY27 NPAT to be materially below FY26

Full summary

Monash IVF Group Limited (ASX: MVF) has issued a trading update for the period from 1 July 2026 to 20 November 2026 (YTD FY27). The Australian stimulated-cycle market contracted by 3.2% in Q1 FY27, with MVF's 12-month rolling market share remaining stable at 19.4%. MVF faced increased fixed costs and supplier price hikes, impacting earnings quality. The company's structural productivity transformation program aims to deliver $8-11 million in annualised savings, though benefits are expected over a longer period. Due to Q1 earnings quality, softened volumes, and uncertain market conditions, Monash IVF expects its underlying FY27 NPAT to be materially below FY26 and current analyst consensus estimates.

Guidance

Monash IVF expects underlying FY27 NPAT to be materially below FY26

Outlook

Monash IVF expects its underlying FY27 NPAT to be materially below FY26 and current analyst consensus estimates, assuming no improvement in market activity in H2 FY27.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in